In our study, we observed a more than two-fold significant reduction in the frequency of MAIT cells among CD3+ T cells, and an almost significant trend towards reduction among CD8+ T cells (Table 5, Figures 4B, D) in T2D patients compared to both HD and individuals with T1D. This evidence concerns the gene CD8A and type 2 diabetes mellitus.